Wistar Institute ( Wistar Institute )

Wistar Institute

Wistar Institute's picture

The Wistar Institute is the nation’s first independent institution devoted to medical research and training. The Wistar Institute has evolved from its beginnings as an anatomical teaching museum to its present-day status as an international leader in basic biomedical research.

In 1972, The Wistar Institute was designated a National Cancer Institute Cancer Center in basic research—a distinction it holds to this day.

Wistar discoveries have led to the development of vaccines for rabies, rubella, and rotavirus, the identification of genes associated with breast, lung, and prostate cancer, and the development of monoclonal antibodies and other significant research technologies and tools.

Wistar Institute press release, blog etc

10/05/2017 - 07:22 NIH Selects Wistar Scientist Kavitha Sarma, Ph.D., for New Innovator Award
10/05/2017 - 06:44 DNA-based Zika Vaccine Candidate is Safe and Effective at Inducing Immune Response
09/27/2017 - 09:44 Melanoma Cells Rewire Their Signaling Pathways to Resist Drug Treatment
09/26/2017 - 08:53 Study Investigates Novel Immunotherapeutic Delivery Strategy for Preventing Infection with Antibiotic Resistant Bacteria
09/20/2017 - 11:06 Characterization of a Slowly Proliferating Population of Melanoma Cells with High Metastatic Properties
09/19/2017 - 13:18 Tumor-infiltrating B Lymphocytes Promote Melanoma Progression and Resistance to Therapy
09/11/2017 - 17:46 A Newly Identified Mitochondrial Metastasis Suppressor Pathway Controls Metabolic Reprogramming of Tumor Cells
09/11/2017 - 11:27 Modulating T-Cell Metabolism Uncovers New Technology for Enhancing Immunotherapy
09/07/2017 - 09:50 New Link Established Between a Molecular Driver of Melanoma Progression and Novel Therapeutic Agent
08/23/2017 - 10:45 Outstanding Investigator Grant Awarded to Dario C. Altieri, M.D., Wistar President and CEO
08/17/2017 - 08:30 Wistar Scientists Develop Novel Immunotherapy Technology for Prostate Cancer
07/24/2017 - 08:27 New Therapeutic Approach for Difficult-to-Treat Subtype of Ovarian Cancer Identified
07/13/2017 - 17:49 The Wistar Institute Appoints Two New Board Members
07/11/2017 - 14:14 Entinostat Therapy Plays Favorable Role in Targeting the Tumor Microenvironment to Enhance Immune Checkpoint Therapy
07/07/2017 - 07:53 The Wistar Institute Welcomes Brian Keith, Ph.D., as the First-ever Dean of Biomedical Studies
07/06/2017 - 12:35 New Synthetic DNA-Based Strategy Shows Promise Against a Diverse Range of Influenza Viruses
07/05/2017 - 10:06 The Wistar Institute Welcomes Chi Van Dang, M.D., Ph.D., as Professor
05/30/2017 - 17:40 Wistars New Biomedical Research Technician Training Program Obtains First State Approval as Non-Traditional Apprenticeship to Support Regions Life Sciences Workforce